Brind.
  1. Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
  2. Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
  3. Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
  4. Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.

AI Adoption in Corporate Hubs Accelerates Automation Across Global Business Functions

4 reports, 4 independent Updated May 28
Gone quiet Reached 4 outlets in its first 24 hours
Reports
4
Developments
12
Repetition
50%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

Global Capability Centres (GCCs) in India are increasingly deploying artificial intelligence and machine learning across corporate functions such as marketing, finance, and human resources. These centers are automating time-consuming tasks that previously required manual effort. For example, Indian hospital chain Apollo Hospitals has adopted an AI clinical assistant developed with Microsoft to help doctors gather patient data and generate insights quickly. Furthermore, companies like Catalyst Brands are piloting computer-generated imagery to create product visuals and videos.

From kathmandupost.com, newsindiatimes.com

Why it matters

Some supportBrind's analysis of the reports

The widespread adoption of AI in these corporate hubs demonstrates a major shift in how global business operations are being conducted. This trend allows companies to drive far-reaching innovations by integrating AI into their core business processes and products.

From kathmandupost.com

Who's involved

How it developed

Newest first. Tap a step to see who reported it.
  1. CRO Partner and NetraMark have formed a partnership to utilize artificial intelligence for the analysis of clinical trial data.Sub-event
  2. HubRx AI integrates with leading Large Language Models (LLMs) to streamline prescription hub services.Sub-event
  3. Recursion Pharmaceuticals, Merck KGaA, and Tempus expanded collaborations to leverage multimodal datasets and launch AI models for drug discovery.Sub-event
  4. Every Cure and Predictive Oncology Inc. formed a strategic collaboration to use AI for drug repurposing.Sub-event
  5. Tempus AI and Northwestern Medicine partnered to enhance AI-powered clinical care and boost investor confidence.Sub-event
  6. Viva Biotech and V-DEL are utilizing technology to support continuous drug discovery and target triage.Sub-event
  7. Sino Biological, Inc. published research on AI protein design validation and listed on the Shenzhen Stock Exchange.Sub-event
  8. Council negotiates with developer Catalyst regarding project inclusion.Sub-event
Show 4 earlier steps
  1. IAIRO has partnered with The Indian Pharmaceutical Association (IPA) as an Anchor Partner, focusing on India's core challenges.Sub-event
  2. Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sub-event
  3. AI is being used by drug companies for patient data, influencer identification, and CGI prototyping.1 source
  4. Amgen and AstraZeneca are deploying AI clinical assistants and piloting CGI to accelerate drug development.1 source

Keep exploring

Part of

Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.

Also in this story

All 12 developments

Within Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.

The entities involved

Related events

Coverage

Newest first; wire copies grouped